Related Experiment Video
Updated: Jun 1, 2026
12:29
Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Anidulafungin: when and how? The clinician's view.
Jomy George1, Annette C Reboli
1Department of Pharmacy Practice and Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA. j.george@usp.edu
Mycoses
|June 15, 2011
Summary
Anidulafungin is a new antifungal drug effective against Candida species, including resistant strains. It shows good tolerability and efficacy in treating candidiasis without significant drug interactions or dosage adjustments.
Area of Science:
- Pharmacology
- Infectious Diseases
- Mycology
Background:
- Anidulafungin represents a novel echinocandin antifungal agent.
- It targets the fungal cell wall synthesis pathway.
- Addresses the need for new treatments against resistant fungal infections.
Purpose of the Study:
- To review the profile of Anidulafungin.
- To highlight its efficacy and safety in treating fungal infections.
- To discuss its unique pharmacokinetic and pharmacodynamic properties.
Main Methods:
- Clinical trial data review.
- Pharmacological studies analysis.
- Efficacy and safety assessments.
Main Results:
- Anidulafungin exhibits fungicidal activity against Candida species, including azole and polyene-resistant isolates.
- It demonstrates fungistatic activity against Aspergillus species.
- No clinically significant drug interactions were observed, and no dosage adjustments are needed for renal or hepatic impairment.
- Anidulafungin was well-tolerated in clinical trials.
Conclusions:
- Anidulafungin is a well-tolerated and effective option for candidiasis treatment.
- Its favorable drug interaction profile and lack of need for dosage adjustments in organ impairment make it a valuable therapeutic choice.
- Anidulafungin expands treatment options for invasive fungal infections.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...